Aspirin and intracerebral hemorrhage: Where are we now?
- PMID: 29443177
- PMCID: PMC5764423
- DOI: 10.1212/CPJ.0000000000000089
Aspirin and intracerebral hemorrhage: Where are we now?
Abstract
For the past 3 decades, aspirin has been widely used for prevention of ischemic stroke and myocardial infarction. Although the evidence supporting the effectiveness of aspirin in prevention of vascular events is clear, data regarding the risk of acute and recurrent intracerebral hemorrhage related to the use of this medication have been conflicting. We review past and contemporary data on aspirin use in relation to intracerebral hemorrhage.
References
-
- Weiss HJ, Aledort LM. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967;2:495–497. - PubMed
-
- Albers GW. Antithrombotic agents in cerebral ischemia. Am J Cardiol. 1995;75:34B–38B. - PubMed
-
- Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res. 2003;110:255–258. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous